CareDx to Report Fourth Quarter and Full Year 2020 Financial Results

Rhea-AI Summary

CareDx, Inc. (CDNA) will release its financial results for the fourth quarter and full year 2020 after market close on February 24, 2021. A conference call is scheduled for 1:30 p.m. PT / 4:30 p.m. ET, with dial-in numbers available for domestic and international callers. CareDx is renowned for its precision medicine solutions for transplant patients, offering testing services and digital healthcare solutions.

Positive

• Upcoming financial results announcement for Q4 and full year 2020 could provide insights into company performance.
• CareDx is positioned as a leading provider of genomics-based information for transplant patients.

Negative

• None.

SOUTH SAN FRANCISCO, Calif., Feb. 12, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it will report financial results for the fourth quarter and full year 2020 after market close on Wednesday, February 24, 2021. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Individuals interested in listening to the conference call may do so by dialing 877-705-6003 for domestic callers or 201-493-6725 for international callers. Please reference Conference ID: 13715410. To listen to a live webcast, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com.

About CareDx
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

CONTACTS:
Greg Chodaczek
347-620-7010
investor@caredx.com

FAQ

When will CareDx report its financial results for Q4 2020?

CareDx will report its financial results for the fourth quarter and full year 2020 on February 24, 2021.

What time is the CareDx conference call on February 24, 2021?

The conference call will begin at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

How can I listen to the CareDx conference call?

You can listen to the conference call by dialing 877-705-6003 for domestic callers or 201-493-6725 for international callers. A live webcast will also be available on CareDx's investor relations website.

What is CareDx known for?

CareDx is known for its precision medicine solutions focused on the healthcare needs of transplant patients.